167 related articles for article (PubMed ID: 26166228)
21. Phase II trial on neoadjuvant intravenous and trans-uterine arterial chemotherapy for locally advanced bulky cervical adenocarcinoma.
Tsubamoto H; Maeda H; Kanazawa R; Ito Y; Ohama N; Hori M; Ikeda Y; Kato T; Sakane R; Hirota S
Gynecol Oncol; 2013 Apr; 129(1):129-34. PubMed ID: 23333929
[TBL] [Abstract][Full Text] [Related]
22. Mesonephric carcinomas and adenocarcinomas of the cervix in children.
Fawcett KJ; Dockerty MB; Hunt AB
J Pediatr; 1966 Jul; 69(1):104-10. PubMed ID: 5935751
[No Abstract] [Full Text] [Related]
23. Mesonephric adenocarcinomas of the uterine cervix: a study of 11 cases with immunohistochemical findings.
Silver SA; Devouassoux-Shisheboran M; Mezzetti TP; Tavassoli FA
Am J Surg Pathol; 2001 Mar; 25(3):379-87. PubMed ID: 11224609
[TBL] [Abstract][Full Text] [Related]
24. Malignant mesonephric neoplasms of the uterine cervix. A report of eight cases, including four with a malignant spindle cell component.
Clement PB; Young RH; Keh P; Ostör AG; Scully RE
Am J Surg Pathol; 1995 Oct; 19(10):1158-71. PubMed ID: 7573674
[TBL] [Abstract][Full Text] [Related]
25. Mixed Mesonephric Adenocarcinoma and High-grade Neuroendocrine Carcinoma of the Uterine Cervix: Case Description of a Previously Unreported Entity With Insights Into Its Molecular Pathogenesis.
Cavalcanti MS; Schultheis AM; Ho C; Wang L; DeLair DF; Weigelt B; Gardner G; Lichtman SM; Hameed M; Park KJ
Int J Gynecol Pathol; 2017 Jan; 36(1):76-89. PubMed ID: 27532149
[TBL] [Abstract][Full Text] [Related]
26. Development of criteria for ovarian preservation in cervical cancer patients treated with radical surgery with or without neoadjuvant chemotherapy: a multicenter retrospective study and meta-analysis.
Hu T; Wu L; Xing H; Yang R; Li X; Huang K; Jia Y; Zhang Q; Chen Z; Wang S; Liu D; Han X; Lin Z; Qu P; Cai H; Song X; Tian X; Wang H; Wang S; Xie X; Li S; Ma D
Ann Surg Oncol; 2013 Mar; 20(3):881-90. PubMed ID: 23054110
[TBL] [Abstract][Full Text] [Related]
27. Mesonephric adenocarcinoma of the uterine cervix and literature review.
Anagnostopoulos A; Ruthven S; Kingston R
BMJ Case Rep; 2012 Dec; 2012():. PubMed ID: 23230242
[TBL] [Abstract][Full Text] [Related]
28. Florid mesonephric hyperplasia of the cervix: a report of a case with review of the literature.
Ayroud Y; Gelfand MM; Ferenczy A
Int J Gynecol Pathol; 1985; 4(3):245-54. PubMed ID: 2414240
[TBL] [Abstract][Full Text] [Related]
29. Mesonephric adenocarcinoma of the uterine cervix: a case report with immunohistochemical and ultrastructural studies.
Fukunaga M; Takahashi H; Yasuda M
Pathol Res Pract; 2008; 204(9):671-6. PubMed ID: 18374498
[TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancer.
Salihi R; Leunen K; Van Limbergen E; Moerman P; Neven P; Vergote I
Gynecol Oncol; 2015 Dec; 139(3):447-51. PubMed ID: 26050921
[TBL] [Abstract][Full Text] [Related]
31. PAX2 distinguishes benign mesonephric and mullerian glandular lesions of the cervix from endocervical adenocarcinoma, including minimal deviation adenocarcinoma.
Rabban JT; McAlhany S; Lerwill MF; Grenert JP; Zaloudek CJ
Am J Surg Pathol; 2010 Feb; 34(2):137-46. PubMed ID: 20061933
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors of primary adenocarcinoma of the uterine cervix.
Chen RJ; Chang DY; Yen ML; Lee EF; Huang SC; Chow SN; Hsieh CY
Gynecol Oncol; 1998 May; 69(2):157-64. PubMed ID: 9600824
[TBL] [Abstract][Full Text] [Related]
33. [Adenocarcinoma of the uterine cervix. Cyto-histologic correlations in 17 cases].
Marzullo F
Pathologica; 1982; 74(1032):463-76. PubMed ID: 7162863
[No Abstract] [Full Text] [Related]
34. Large cell neuroendocrine carcinoma of the uterine cervix associated with adenocarcinoma.
Ko ML; Jeng CJ; Huang SH; Shen J; Chen SC; Tzeng CR
Taiwan J Obstet Gynecol; 2007 Mar; 46(1):68-70. PubMed ID: 17389194
[TBL] [Abstract][Full Text] [Related]
35. Mesonephric Adenocarcinoma of Uterine Cervix: A Case Report and Review of the Literature.
Nili F; Salarvand S; Saffar H; Kalaghchi B; Ghalehtaki R
Iran J Pathol; 2021; 16(2):227-231. PubMed ID: 33936235
[TBL] [Abstract][Full Text] [Related]
36. How often parametrial involvement leads to post-operative adjuvant treatment in locally advanced cervical cancer after neoadjuvant chemotherapy and type C radical hysterectomy?
Martinelli F; Bogani G; Ditto A; Carcangiu M; Papadia A; Lecce F; Chiappa V; Lorusso D; Raspagliesi F
Eur J Surg Oncol; 2015 Aug; 41(8):1089-96. PubMed ID: 25890492
[TBL] [Abstract][Full Text] [Related]
37. When Does Neoadjuvant Chemotherapy Really Avoid Radiotherapy? Clinical Predictors of Adjuvant Radiotherapy in Cervical Cancer.
Papadia A; Bellati F; Bogani G; Ditto A; Martinelli F; Lorusso D; Donfrancesco C; Gasparri ML; Raspagliesi F
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S944-51. PubMed ID: 26268452
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic Characteristics of Mesonephric Adenocarcinomas and Mesonephric-like Adenocarcinomas in the Gynecologic Tract: A Multi-institutional Study.
Pors J; Segura S; Chiu DS; Almadani N; Ren H; Fix DJ; Howitt BE; Kolin D; McCluggage WG; Mirkovic J; Gilks B; Park KJ; Hoang L
Am J Surg Pathol; 2021 Apr; 45(4):498-506. PubMed ID: 33165093
[TBL] [Abstract][Full Text] [Related]
39. Second case of uterine mesonephric adenocarcinoma.
Marquette A; Moerman P; Vergote I; Amant F
Int J Gynecol Cancer; 2006; 16(3):1450-4. PubMed ID: 16803547
[TBL] [Abstract][Full Text] [Related]
40. Adenocarcinoma of the cervix: should we treat it differently?
Williams NL; Werner TL; Jarboe EA; Gaffney DK
Curr Oncol Rep; 2015 Apr; 17(4):17. PubMed ID: 25708801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
